Archive for the ‘Viruses’ Category

Vaccines Likely Infected With Retroviruses & Linked to Chronic Disease

https://articles.mercola.com/sites/articles/archive/2018/12/09/retrovirus.aspx?

Plague: One Scientist’s Intrepid Search for the Truth About Human Retroviruses and Chronic Disease

 Approx 3 Min

Written by Dr. Joseph Mercola

Story at-a-glance

  • A retrovirus is a virus that contains RNA encoded genes rather than DNA. Using reverse transcriptase, the retrovirus is able to transform the single-stranded RNA into a double-stranded DNA
  • When the retrovirus infects a host, it integrates its DNA into the DNA of the host cell, which allows the retrovirus to replicate itself and spread through the host
  • One example of a transmissible retrovirus is the HIV virus, which can cascade into the clinical symptoms of acquired immunodeficiency syndrome (AIDS)
  • A retrovirus family known as xenotropic murine leukemia virus-related viruses (XMRV) may play a causal role in chronic fatigue syndrome, chronic myalgic encephalopathy (ME) and other diseases, including autism
  • Some retroviruses, including XMRV (but not HIV as far as we know), infect your germ cells, which means they are transmitted to your offspring

Judy Mikovits, Ph.D., a virologist, researcher and founding research director of the Whittemore Peterson Institute — which researches and treats chronic fatigue syndrome (CFS) in Reno, Nevada — got embroiled in controversy when, in 2009, she was the senior author on a paper which reported that a retrovirus known as xenotropic murine leukemia virus-related virus (XMRV) may play a causal role in CFS and other diseases, including autism.

Her book, “Plague: One Scientist’s Intrepid Search for the Truth About Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism and Other Diseases,” details her research and personal trials that arose as a consequence of her work.

“Kent Heckenlively essentially wrote it,” Mikovits says, “because I write like a scientist. We wrote it using the genre of flashback. He taped hours and hours of me telling the story as he asked me questions — because he’s trained as an attorney — and then he turned that into this suspense-thriller. Interestingly enough, it almost has to read like fiction because of the lawyers it took to … make sure we weren’t sued.”

What Are Retroviruses?

Before we go further, let’s review what a retrovirus is. A retrovirus is a ribonucleic acid (RNA) virus — in other words, a virus that contains RNA encoded genes rather than deoxyribonucleic acid (DNA). Using reverse transcriptase, the retrovirus is able to transform the single-stranded RNA into a double-stranded DNA.

When the retrovirus infects a host, it integrates its DNA into the DNA of the host cell, which allows the retrovirus to replicate itself and spread through the host. As more and more cells are infected, you become increasingly sicker. Mikovits explains:

“Humans have a DNA genome. Our blueprint is DNA. Retroviruses have an RNA genome, but they also are unique in the RNA family of viruses, where their RNA genome is reverse-transcribed. That is, written backwards by an enzyme unique to retroviruses called reverse transcriptase. That enzyme writes the RNA into DNA.

Then they have another enzyme called integrase. Integrase is like a pair of scissors that cuts open your DNA and then inserts the retrovirus, which is only about 8,000 base pairs, a very, very, very small virus, 50 to 100 nanometers on an electron micrograph. That piece of DNA — called a provirus — is now in the DNA of your cells forever. Every time your cells replicate, you make more viruses.”

Now, this DNA insertion has been ongoing throughout human history. According to Mikovits, about 10 percent of the human genome is retroviral in origin. These are called human endogenous retroviruses. These, however, differ in that they’ve been crippled in part by our DNA methylation machinery (which modulates genes expression and the human immune system — so that they can no longer make complete viruses and therefore cannot infect others.

However, when you’re infected with a retrovirus such as human T-lymphotropic virus (HTLV-1), HIV HBRV or Borellia as in chronic Lyme disease and develop DNA methylation and immune dysfunction, these endogenous retroviruses begin to be expressed, and this is yet another really important finding.

HIV — One Example of a Transmissible Retrovirus

One example of a transmissible retrovirus is the HIV virus, which can cascade into the clinical symptoms of acquired immunodeficiency syndrome (AIDS). HIV was discovered in 1982, and as mentioned above, was part of Mikovits’ early research work. Her book includes the history of that important discovery.

When Mikovits first began studying retroviruses, HIV/AIDS was completely unknown, but they suspected a retrovirus was at play because of how retroviruses affect the human immune system and lead to acquired immune deficiencies and cancers.

“You don’t just one day get this virus and you’re sick. In fact, we now know millions of people have HIV and will never develop AIDS. We talk about that in the book, because the book ultimately is one of hope that we fix HIV.

I can honestly tell you in 1999, when I was running the lab of antiviral drug mechanisms, I did not ever expect we would solve that problem. Now, AIDS patients on antiretroviral therapy are probably healthier and develop fewer cancers … than most of the rest of society.”

Some retroviruses, including XMRV (but not HIV), also infect your germ cells, which means they not only cause continuous infection in your body but also transfer to your offspring.

XMRV, the xenotropic murine (mouse) leukemia retrovirus, is the mouse-related retroviruses that cause cancer and lots of neurological diseases. Those affect the stem cells, the egg, the sperm — every cell in your body. That was one of the big ‘Oh, my Gods,’ about our discovery,” Mikovits says.

When it comes to treatment, the key is to keep the virus silent, because when they’re not, each time your cells divide you’re making more retroviruses. For this, antiretroviral treatments are used, some of which will be discussed later in this article.

From AIDS to ME/CFS

After 9/11, Mikovits started working with a woman whose daughter was severely ill with chronic fatigue syndrome. “Basically, that was the first time I ever saw the disease called ME/CFS,” she says.

“This person was looking at a herpes virus known as human herpesvirus 6 (HHV-6). This is a virus prominent in people with Kaposi sarcoma, [which] became associated with HIV and AIDS. Dr. Patrick Moore and Dr. Yuan Chang [discovered] that Kaposi sarcoma was actually caused by a herpes virus — then known as Kaposi sarcoma herpes virus; now, it’s HHV-8.

Because the immune system is crippled, you wake up the sleeping herpes viruses. People with autism, ME/CFS and cancers have a lot of chronic active infections, so we often see the Epstein-Barr virus (EBV) associated with outbreaks of ME/CFS …

This woman introduced me to Dr. Dan Peterson and Annette Whittemore in Incline Village, Nevada, where he had been studying outbreaks of ME/CFS for probably 25 years. He said he had a bank of samples. We went up there. I met all the patients.

I interviewed them in great length and developed a hypothesis, which had actually been shown before by Elaine Defreitas, Ph.D., another scientist many years earlier

Defreitas had isolated retroviruses from patients with ME/CFS. A doctor … named Sidney Grossberg had also isolated retroviruses from at least one patient with ME/CFS. So, the retroviral hypothesis wasn’t new. Everything about it fit …

One of the most severely injured patients at that time was Whittemore’s daughter, Andrea. That summer (2006), I went up there … and started studying it … I used the systems biology approach, because there’s a lot of heterogeneity.

We know AIDS patients who have HIV and will never get AIDS … I interviewed patients in Peterson’s office all summer and took blood, urine, saliva and all kinds of samples to isolate that virus, which is what you need to do to show it’s associated with a disease.”

The Discovery of Infectious Retroviruses

Eventually, she brought together several of her former and current colleagues who were world experts in HIV sequencing to look at ME/CFS. Among them was the world’s leading electron microscopist, Kunio Nagashima, who has done the electron micrographs of every family of human retroviruses discovered: the human beta retrovirus, human delta virus, lenti-virus (such as HIV) and gamma retroviruses.

Working in collaboration with the Cleveland Clinic, Mikovits and her team isolated the virus and spent the better part of 2008 and 2009 putting a paper together, proving the XMRV retrovirus was infectious and transmissible and not just another crippled human endogenous retrovirus.

“To our horror, we learned these [retroviruses] could be aerosolized. This was in 2011 … That was really the first nail in my coffin. Pun intended, because the national academy member, John Coffin, Ph.D. — who had told Frank Ruscetti, ‘There is no such thing as human retroviruses. Don’t study them’ — then made a fortune out of HIV and did everything he could to destroy me and the patients,Mikovits says.

“Prior to publication in 2009, we wrote a patent on the detection of these retroviruses, these pieces and parts as contaminants of the cell cultures, of the cell lines from which we make vaccines. After they destroyed my reputation and career and forced the retraction of our paper from [the journal] Science, Coffin turned around and wrote a patent on the detection of these viruses in contaminating cell linings and contaminating biologicals in our labs.”

This PDF includes emails, letters and supporting documentation showing how the retraction of Mikovits’ Science paper was forced, after which Coffin filed his own patent for a detection method of the contaminants in cell lines used for vaccines and other biologicals. There’s also documentation detailing the scientific fraud Mikovits asserts in this interview.

Infectious Retroviruses May Contaminate Blood Supply and Vaccines

In her book, she also details how infectious retroviruses are still likely infecting many biological solutions used clinically today, such as vaccines and other therapies. To say that this is a concern would be an understatement. Children’s Health Defense discusses this, and more, in “Looking Back, Looking Forward: Cancer and Vaccines.”1 Mikovits explains:

“That was really at the heart of the big ‘Oh, my God.’ The worst I learned in this whole experience is how corrupt scientific journals are. In fact, Ruscetti now calls Science, that prestigious journal, ‘The National Inquirer,’ because they literally engineered the whole thing to destroy MEC/FS patients and any association this virus [XMRV] had with these diseases …

All of the studies showed that the control population was between 3.75 and 6.8 percent infected. When you do a study and there’s evidence of infection in 6 percent of the human population, that’s 25 million Americans. To put that in context, at the height of HIV/AIDS in 1995, it was 1 million Americans. It would crush our health care system if they had to pay for what they caused.”

The result of Mikovits’ findings was nothing short of personal devastation. Not only was her paper retracted by Science, she was even arrested for “stealing” her own lab notes. Charges were ultimately dropped, but the damage to her reputation was a done deal.

“Basically, our paper came out on October 8, 2009. It was literally like ‘the shot heard around the world.’ I was on the road every single day. Everywhere I went doctors were like, ‘She’s got it. She’s got it. She’s got it,’ and not just with MEC/FS but also with cancer, leukemia, lymphoma, with prostate cancer.

When you start looking at the inflammatory events in the acquired immune deficiencies, with autoimmune disease, with Lou Gehrig’s disease, the problem became this [retro]virus. Well, there’s no single virus. There’s no HIV. There’s a whole family of HIVs. There’s an HIV 1. There’s an HIV 2. There’s a strain A, B, C and D.

Why do we do influenza vaccines for this strain de jour or every year? [Because] there are strains of viruses. There are families of viruses … The second that we published this paper, we started working to get a diagnostic test for the blood supply to show it wasn’t contaminated, which, in fact, it was.

Later that year, the last talk I ever gave was on a science paper that came out September 22, 2011 … That talk was basically a debate for the evidence that there are human retroviruses of the XMRV family that aren’t VP62 (the infectious molecular clone, not the natural isolates of our paper).

We could show in the original paper that there was evidence of murine leukemia viruses, gamma retroviruses that were infectious and transmissible, just as we had said.

Coffin was on the other end of that debate. He said it was all a recombination event. He published a paper in 2013 saying, ‘When we worked with mouse cells, they expressed a lot of pieces and parts of retroviruses. This just happened to happen in the laboratory.’

[Hence, he claimed] that’s what we had isolated. [Coffin claimed] that what we were looking at were just contaminants in the laboratory. ‘It’s all a lab contaminant,’ [Coffin said], ‘You can all go home. You’re safe.'”

Massive Public Health Concerns Swept Under the Rug

As one might expect, Mikovits’ research caused massive concern in the professional community, because here was a newly identified, infectious and transmissible retrovirus that no one was screening for, and it was potentially contaminating 10 percent of the human blood supply. But rather than face the problem head on, it was rapidly swept under the proverbial rug.

“My mom was watching Good Morning America one morning. Across the bottom of the ticker tape said, ‘XMRV all a hoax’ … It was horrible. We started to realize our fake news and fake science.”

Today, the blood supply is unlikely to be contaminated, thanks to a decontamination procedure developed by a California-based company called Cerus and which Mikovits proved to inactivate XMRV, rendering it noninfectious.

Other biologicals, including vaccines, however, may not be routinely decontaminated using this process, in large part because they’re not required to do so, and drug companies are not liable for vaccine-induced harm. What’s more, decontaminating the vaccine may render it ineffective.

“It won’t work. It will no longer be a vaccine … The Cerus method cleans up Ebola. It cleans up Zika. It cleans up essentially any RNA viruses, including HIV and all three human retroviruses. The Cerus system is extremely valuable to cleaning up the blood supply.

But they cannot clean up the vaccines for another reason. If they do, they prove Andy Wakefield right. They prove me right. They prove they’ve got 25 million Americans, who they have to support for the rest of their lives and pay damages [to] …”

The Price of Making an Unpopular Scientific Discovery

On a personal level, Mikovits has taken an enormous personal hit. September 29, 2011, she was fired from the Whittemore Peterson Institute for insolence and insubordination, and was driven into bankruptcy after being falsely arrested for stealing her own lab notes. (She never was and to this day is not in possession of her notebooks or any of the two offices full of her work done in her entire career.)

She explains her firing saying that Whittemore had been selling a diagnostic test and the director of their for-profit commercial laboratory was using federal grant funds to do that work (with full knowledge and under the direction of Annette and Harvey Whittemore), which is misappropriation of federal funds. Mikovits became aware of this in August that year, and wrote him off the grant.

“The Whittemores basically fired me immediately in an attempt … to get this scientist, Vince Lombardi, Ph.D. … to recreate the work while I was out of town and say I was a lunatic — that he’d been doing the work all along, and he hadn’t misappropriated any of the funds.

They fired me on September 29 and immediately locked down the entire university to me or my staff … The insolence and insubordination was I had refused a direct order to misappropriate federal funds, basically. I wasn’t ever going to do that. The insolence I’m trying to learn not to do, because it probably would have gone a lot better for me if I didn’t say ‘F-you,’ at the same time …

It was September 22, 2011, when I gave my last talk. They had three weeks to get a Science paper out there that would destroy my reputation in the ME/CFS community … Ruscetti had to sign that paper, or he and Sandy Ruscetti would be fired … [and] lose their entire retirement, which is 75 years.

That was one of the few times I sobbed. I was sitting in my bed screaming …It was 6 o’clock in the morning. They were on the East Coast and they needed to get this paper published fast by Science.

I called the Ruscettis and said, “Frank, they agreed to change the language. They agreed to change the title. They agreed it wasn’t an association study … [they say] we didn’t have a diagnostic test. Either way, the Whittemores are going to kill me because they’re selling the diagnostic test.’

So Frank [Ruscetti] signed the paper. They didn’t change the wording. [What they did] is pure fraud. Here, the head of the National Heart, Lung, and Blood Institute published pure fraud in the journal Science, just as two years later, Ian Lipkin published pure fraud. It is fake news. It is so corrupt, everything about it.

It’s not [the researchers]. It’s the top of the line. It’s Dr. Tony Fauci. We’re only allowed to make incremental advances. When you make a discovery of this nature, it changes all of everything. This is misogyny … This is a bunch of little boys … fighting over who gets credit, while the world dies, while you kill an entire continent.

That’s why I do shows like this. Because we’re going to teach doctors. When doctors understand the science — and they’re coming around a lot — because the science is there. Nothing about our paper, except the sequence of the virus, has ever been wrong. We knew that in the beginning.”

Individuals Infected With Retroviruses Should Avoid Vaccinations

According to Mikovits, retroviruses such as XMRV affect entire families, as it can be transmitted to your offspring. Many of these families also have children with autism, which Mikovits believes may be connected to the retrovirus. The question is, what can you do if you’re infected? For starters, Mikovits recommends avoiding vaccinations.

“Until 2011, not inconsequentially, we didn’t vaccinate AIDS patients the same way. It’s in the book. You don’t vaccinate the immune-compromised … By definition, you have an immune system that doesn’t work. Why would you vaccinate them? Why would you vaccinate somebody under 3 years old, who has an immune and detox systems that don’t work?

This was the key of the RNaseL story (a genetic susceptibility not to degrade RNA viruses), of the Thompson fraudulent paper [Editor’s note: This refers to William Thompson, Ph.D., a former senior scientist at the CDC’s National Center for Immunizations and Respiratory Diseases, who confessed he conspired to cover up links found between the MMR vaccine and autism].

All they had to do was wait for black boys to be 3 years old, and they would have been able to degrade the RNA virus. That’s criminal. That’s beyond comprehension

The pearl of wisdom is this DNA methylation. Keep the violent virus silent … DNA methylation has to silence them. You can’t inject them in a vaccine. We’re injecting millions of pieces in parts of retroviruses in every vaccine, by definition (and admission).

I am working on an ongoing cancer lawsuit that says vaccines cause childhood cancer, a lymphoma. By these same mechanisms, you’ve destroyed the DNA methylation machinery’s ability [to silence the virus]. You’ve simply overwhelmed the substrate. You’ve overwhelmed the ability to methylate.

Every time those viruses integrate, you have a better chance at insertional mutagenesis. Don’t expose anybody to human (or animal) retroviruses. Use antiretroviral therapy, which are natural products … There are lots of natural products. We published on them. Those are actually therapy for these kids.

[A 100-year-old drug called Suramin] was one of the first antiretroviral therapies for HIV … [It] worked best against the murine leukemia virus-related viruses, against the mouse retroviruses, the gamma retroviruses …

[Dr. Robert] Naviaux [professor of medicine, pediatrics and pathology at University of California San Diego School of Medicine] did a small clinical trial.2 These kids got their life back.3 They started talking again. What did Bayer do? They stopped the trial and took the drug away from everyone. Now, you can’t get it …

We could help millions of people get over [autism]. But when you show cure, you know cause. That’s it. I would be right … Millions of people would get their lives back, and it’s all about money.”

XMRV Is a Significant Threat

As mentioned, there are several different retroviruses, which are part of four viral families (delta, lenti, beta and gamma). Aside from HIV and XMRV, there’s the human T-cell leukemia lymphoma virus (HTLV-1) family. There are five or six HTLV viruses, but HTLV-1 is the only one known to cause severe disease.

Human beta retrovirus is another virus associated with primary biliary cirrhosis. Many patients with MEC/FS also have family members with primary biliary cirrhosis. As for which one might be the most significant threat, Mikovits believes XMRV is among the most pressing, because while HIV is well-contained at present, XMRV is not, and it appears to play a significant role in diseases of methylation.

Disturbingly, they’re now using murine leukemia viruses as vectors for gene therapy and a novel cancer therapy called chimeric antigen receptor (CAR) T-cell therapy. In other words, they’re causing cancer and other retroviral illnesses.

The same thing with Gardasil … We’re causing these diseases and we know it because we’re using these [retroviruses] as vectors. We don’t need infectious viruses. That’s one thing that’s really important to know. You don’t need infectious viruses if you’re injecting the provirus, or the pieces and parts. You inject it, past your immunity, past your gut, past RNA cell, past everything. You bypass the immune system. They don’t need to be infectious.

All you need is an envelope to cause that prostate cancer. That’s a paper that was published 2013. In most of our studies, all we detected was the envelope. The envelope alone causes vasculitis … Another strain of XMRV gamma retrovirus from mice was identified by Gary Owens … associated with cardiovascular disease. This is just a nightmare that we’ve unleashed in our environment.”

Retroviruses and ME/CFS

According to Mikovits, 6 to 8 percent of the general population are infected with infectious and transmissible XMRV-retroviruses, and in the chronic fatigue population, that prevalence shoots up to about 30 to 40 percent. As with HIV, antiretroviral therapies can be very helpful in the treatment of ME/CFS, including low-dose naltrexone.

You have to silence the other pathogens, so taking care of mycoplasma, taking care of mold, absolutely supporting the gut microbiome [will help], Mikovits says. “We learned with AIDS and cancer patients that if they don’t have the diversity in the microbiome, just like in autism, just like in MEC/FS, it’s because the retrovirus is causing leaky gut …

The nonspecific inflammation [is] the retroviruses. If you keep the gut healthy, you can heal. The primary is the diversity in the microbiome, or you can’t respond to the drugs. There’s a lot of hope. That’s what we end the show with. There are therapies. We could fix this tomorrow. That’s why I do it.”

To learn more, be sure to pick up a copy of “Plague: One Scientist’s Intrepid Search for the Truth About Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism and Other Diseases,” which reads more like a fictional thriller than a nonfictional book about the science of disease.

________________

For More:  https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

https://madisonarealymesupportgroup.com/2018/03/01/vaccines-could-contribute-to-disease-epidemics-due-to-retrovirus-contamination/

https://madisonarealymesupportgroup.com/2018/06/23/the-role-of-retroviruses-in-chronic-illness-a-clinicians-perspective/

They should make Mikovits’s book into a movie.  It’s beyond belief.

 

 

Acute Flaccid Paralysis is (Most Often) Guillain Barre Syndrome

https://jameslyonsweiler.com/2018/12/01/acute-flaccid-paralysis-is-most-often-guillain-barre-syndrome/

ACUTE FLACCID PARALYSIS IS (MOST OFTEN) GUILLAIN BARRE SYNDROME

by jameslyonsweiler

The US press has been pushing a view of acute flaccid paralysis as a mysterious condition of unknown etiology (unknown cause). Checking the scientific literature, however, tells us that AFP is most often Guillain Barre Syndrome, a condition that appears on the National Vaccine Injury Compensation Program as a “Table Condition” – i.e., one that the US HHS has no defense against when parents file in the NVICP for compensation for GBS as a vaccine injury in their children.

Here are some quotes from the abstracts of a collection of studies on AFP:

“Within the last few years, an enterovirus D68 outbreak has been associated with cases of acute flaccid paralysis in children, and emerging Zika virus infection has been concurrent with cases of acute flaccid paralysis due to Guillain-Barré syndrome, although cases of myelitis have also been reported.”

“Cases (of AFP) exhibited heterogeneous paralysis patterns from 1- to 4-limb involvement, but all definite cases had longitudinal spinal gray matter lesions on magnetic resonance imaging (median, 20 spinal segments). Cerebrospinal fluid pleocytosis was observed in 50 of 59 cases (85%), and 8 of 29 (28%) were positive for antiganglioside antibodies, as frequently observed in Guillain-Barré syndrome.”

“The syndrome of acute flaccid paralysis (AFP) is a common medical emergency in children. In the era of poliomyelitis eradication, the common causes of AFP include Guillain-Barré syndrome (GBS), transverse myelitis and traumatic neuritis.”

“One-hundred thirty-nine children aged <15 years were reported to the Center for Diseases Control with AFP. In 138 (99%) stool samples no poliovirus was isolated. None of the patients was diagnosed as having acute poliomyelitis or polio-compatible paralysis. Guillain-Barré syndrome was the most frequent final diagnosis (79 cases) followed by Transverse Myelitis (7 cases) and Encephalitis (6 cases).”

“The major clinical diagnoses associated with AFP were Guillain-Barré Syndrome (GBS, 40%) and encephalomyelitis/myelitis (13%).”

Guillain-Barré syndrome represented more than half of the reported cases (of AFP) (N = 2611, 52.5%), followed by traumatic neuritis (N = 715, 14.4%), and other CNS infections (N = 292, 5.9%).”

“Guillain-Barré syndrome represented more than half of the reported cases (of AFP) (N = 2611, 52.5%), followed by traumatic neuritis (N = 715, 14.4%), and other CNS infections (N = 292, 5.9%).”

“Of these (cases of AFP), nineteen (45%) cases were classified as Guillain-Barré syndrome on both registries.”

“In 44.5% of cases (of AFP) the definite diagnosis was Guillain Barrè syndrome.”

Guillain-Barre syndrome dominated among non-polio AFP (39.3% of cases); more rare were traumatic neuritis (27.9% of cases), transient monoparalysis (12.1%), myelitis (7.6%).”

“A neurological cause was identified in 67.5% of cases (of AFP), of which the most common was Guillain-Barre syndromee (42%), followed by transverse myelitis (15%)”

“The major clinical diagnosis associated with AFP were Guillain-Barre syndrome (30.2%), central nervous system infection (16.2%), transverse myelitis (10.6%) non-polio enterovirus infection (6.2%), and hypokalaemic paralysis (5.2%).”

“Among (AFP cases), Guillain-Barré syndrome (118 cases, 41.5% of all non-polio AFP cases), traumatic neuritis (63 cases, 22.2%), transient monoparesis of limb (35 cases, 12.3%), myelitis (26 cases, 9.2%) were registered most frequently.

“To describe the epidemiology and causes of acute flaccid paralysis (AFP) in Australian children, and the clinical features of the two most common causes of AFP, Guillain-Barré syndrome and transverse myelitis.”

“The most common causes of AFP were Guillain-Barré syndrome in 67 (47%) and transverse myelitis in 27 (19%)”

Guillain-Barré syndrome was the commonest single cause of AFP.”

“…acute flaccid paralysis (AFP) attributed to a peripheral demyelinating process (Guillain-Barré Syndrome [GBS]), or to an anterior myelitis.”

Additional Information:

How to file your vaccine injury in VAERS

How to file a case in the National Vaccine Injury Compensation Program

AFP IS GBS ABSTRACTS <<< download the abstracts

________________

**Comment**

I’ve been sitting on this article until today when it seemed appropriate to repost due to this:  https://madisonarealymesupportgroup.com/2018/12/07/nevada-man-diagnosed-with-guillain-barre-syndrome-after-getting-flu-shot/

Various vaccines are definitely causing GBS.

https://madisonarealymesupportgroup.com/2018/10/19/rise-in-acute-flaccid-myelitis-cases-and-the-link-to-vaccinations/

https://madisonarealymesupportgroup.com/2016/11/07/connection-of-acute-flaccid-myelitis-and-vaccinations/ The connection between vaccination and paralysis has been known since the 40’s and 50’s and was written about in The Lancet by Stephen Mawdsley in an article titled, “Polio Provocation: Solving a Mystery With the Help of History.”

Mawdsley states:

“The application of epidemiological surveillance and statistical methods enabled researchers to trace the steady rise in polio incidence along with the expansion of immunization programs for diphtheria, pertussis, and tetanus. A report that emerged from Guy’s and Evelina Hospitals, London, in 1950, found that 17 cases of polio paralysis developed in the limb injected with pertussis or tetanus inoculations. Results published by Australian doctor Bertram McCloskey also showed a strong association between injections and polio paralysis. Meanwhile, in the USA, public health researchers in New York and Pennsylvania reached similar conclusions.Clinical evidence, derived from across three continents, had established a theory that required attention.”

So what happened to this theory that piercing the skin during injection drives the polio virus into deep tissue where it then enters the central nervous system where it ultimately leads to paralysis and even death?

Good question.

The theory was essentially proven in 1998 in an article titled, “Mechanism of Injury-Provoked Poliomyelitis,” in the Journal of Virology. Researchers state:

Skeletal muscle injury is known to predispose its sufferers to neurological complications of concurrent poliovirus infections. This phenomenon, labeled ‘provocation poliomyelitis,’ continues to cause numerous cases of childhood paralysis due to the administration of unnecessary injections to children in areas where poliovirus is endemic. Recently, it has been reported that intramuscular injections may also increase the likelihood of vaccine-associated paralytic poliomyelitis in recipients of live attenuated poliovirus vaccines. We have studied this important risk factor for paralytic polio in an animal system for poliomyelitis and have determined the pathogenic mechanism linking intramuscular injections and provocation poliomyelitis.  Skeletal muscle injury induces retrograde axonal transport of poliovirus and thereby facilitates viral invasion of the central nervous system and the progression of spinal cord damage. The pathogenic mechanism of provocation poliomyelitis may differ from that of polio acquired in the absence of predisposing factors.”

It’s such a big deal that even the CDC has created a AFM Task Force:  https://thevaccinereaction.org/2018/11/cdc-creates-afm-task-force/  While the cause of AFM remains a mystery, Nancy Messonnier, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases recently said that AFM “seems to be more of an autoimmune syndrome, as opposed to a direct result of a virus.” She has also compared AFM to what happens with the autoimmune neurological disorder known as Guillain-Barré Syndrome, in which the immune system attacks healthy nerve cells in the peripheral nervous system.7 8 

Why do I get the impression that the CDC will state that while the cause of AFM is a mystery, it’s DEFINITELY NOT VACCINES.

In early November the CDC blamed a virus:  https://thevaccinereaction.org/2018/11/under-siege-by-critics-cdc-moves-to-blame-a-virus-for-polio-like-cases-of-afm/

BTW:  in 1995, Swiss Scientists found reverse transcriptase in the live measles & mumps vaccine as well as some influenza vaccines.  https://thevaccinereaction.org/2018/11/virus-enzyme-found-in-mmr-vaccine/  Excerpt:

RT activity is associated with the presence of retroviruses, a class of viruses that can permanently alter the genes of the cells they infect. AIDS is a retrovirus. Scientists at Merck & Co., the US manufacturer of MMR vaccine, are reportedly trying to find out where the RT came from. One possibility is that the RT activity in MMR vaccine signals the presence of an avian leucosis virus (AVL), a retrovirus that infects some birds and can cause a leukemia-like illness.

Another possibility is that the chickens used to make the vaccine carry RT coding genes derived from retroviruses that infected the species tens of thousands of years ago.

Mind you, this was going on in 1995.  The CDC’s response:  Continue vaccinating in spite of chicken viruses being in vaccines!

And now, to prevent absenteeism, kids are getting the Flu Shot in the Classroom for convenience:  https://thevaccinereaction.org/2018/12/children-given-flu-shots-in-school-classrooms/  “Healthy Schools, LLC,” was founded by former Jacksonville Jaguars pro-football player Tony Boselli and   is getting paid to handle the entire vaccination program.  Boselli recently sold the entity to CareDox, Inc. of New York, where he remains as a partner and President.  CareDox IS a for-profit company with investors.  The program hopes to give the jab to 600,000 kids in 8 states for free due to reimbursement contracts with Medicaid & other insurance providers.  The really scary aspect of this program is there are no physical exams or histories taken.  There is no mention of monitoring for adverse reactions and/or reporting to VAERS (Vaccine Adverse Event Reporting System).  It appears everything about the program is handled digitally and there also remains the question of informed consent.

https://www.nvic.org/NVIC-Vaccine-News/December-2018/internet-police-protect-you-from-freedom-of-speech.aspx? Barbara Loe Fisher explains in an informative video that we may not be able to find information about vaccine science, policy and law due to the cancellation of net neutrality in 2017.  She states that the public-private business partnership between government and corporations/institutions has, “cleared the way for factual information about health to be censored as ‘fake news’ and quietly removed from the internet if it does not conform with public health policy and government recommendations for use of pharmaceutical and food products.”  Also within this link is the story of a nurse who was fired for refusing the Flu shot.

This will affect much more than vaccine information.

It will affect the juggernaut of Lyme/MSIDS as well as any other politically incorrect disease.

ATA190 Cell Therapy – Could This Work for Some Lyme/MSIDS Patients?

https://multiplesclerosisnewstoday.com/2018/11/21/phase-1-trial-ata190-cell-therapy-shows-promise-treating-progressive-ms/

Phase 1 Trial of ATA190 Cell Therapy Shows Promise in Treating Progressive MS

Phase 1 Trial of ATA190 Cell Therapy Shows Promise in Treating Progressive MS

Atara Biotherapeutics’ investigational ATA190, a cell therapy that wipes out immune B-cells infected with the Epstein-Barr virus (EBV), led to neurological improvements and reduced symptoms in patients with primary and secondary progressive multiple sclerosis (MS), a Phase 1 trial shows.

The trial results were published in the Journal of Clinical Investigation Insightin a study titled “Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

ATA190 is a T-cell immunotherapy that targets immune B-cells and plasma cells in the brain and spinal cord that have been infected with EBV. There is increasing evidence linking EBV infection with MS.

ATA190 is made from a patient’s own (autologous) immune cells, which are collected and modified in a lab to target the EBV-infected cells, then infused back into the patient’s blood. The goal is for the modified immune T-cells to recognize EBV-infected B-cells and kill them.

The Phase 1 trial (ACTRN12615000422527), conducted at the QIMR Berghofer Medical Research Institute and The University of Queensland, in Australia, evaluated the safety and efficacy of ATA190 as a treatment for progressive MS.

The study enrolled 10 patients — five with primary progressive MS (PPMS) and five with secondary progressive MS (SPMS). Patients had experienced progressive neurological deterioration due to MS for a mean of 10.1 years.

Participants were treated with four escalating doses of ATA190, administered intravenously over a period of eight weeks. The lowest and first dose was 5 million modified T-cells, followed by doses of 10, 15, and 20 million. Patients were followed for 27 weeks after the first infusion.

Results showed that ATA190 was well-tolerated, with no severe adverse events detected during the study. One patient experienced a potential treatment-related adverse event — dysgeusia, a distortion of the sense of taste.

Efficacy was measured by several parameters, including changes in the Expanded Disability Status Scale (EDSS) score, fatigue, as well as cognitive and other neurological parameters. Researchers also analyzed patients’ brains by magnetic resonance imaging (MRI) and tested their cerebrospinal fluid (CSF) — the liquid around the brain and spinal cord — for the presence of antibodies.

Seven of the 10 patients had improvements in neurological parameters — such as increased productivity, cognition, and word finding — accompanied by a reduction in symptoms. These benefits began two to 14 weeks after the first infusion.

Fatigue, one of the most disabling and hard-to-manage symptoms of MS, was reduced across the group — the median Fatigue Severity Scale score was lower at week 27 compared to the beginning of the study. This decrease, however, didn’t reach statistical significance.

Analysis of the CSF showed that levels of antibodies were reduced at the end of the study in four out of nine patients. Moreover, three of those four patients showed neurological improvements.

Patients received T-cells with different degrees of reactivity against EBV. Six patients who received T-cells with strong EBV reactivity showed clinical improvement; three of those experienced improvements in the EDSS score.

The other four patients received T-cells with weak EBV reactivity; of these, one showed improvement. None experienced a change in the EDSS score.

The team said that overall, the results show that the benefits seen are linked with T-cell effects.

“We previously presented promising initial ATA190 results in patients with progressive MS, and [now] the published results confirm our earlier observations,” Professors Michael Pender, of The University of Queensland, and Rajiv Khanna, coordinator of QIMR Berghofer Centre for Immunotherapy and Vaccine Development, the study’s lead authors, said in a press release.

“Findings from the study support growing evidence that targeting EBV-positive B-cells is a potential novel treatment modality for MS and merit additional investigation,” Pender and Khanna said.

“T-cell therapy targeting only EBV-infected B-cells is a treatment modality that could offer favorable safety and durable efficacy,” they wrote, adding that their work “sets the stage for further clinical trials with autologous and allogeneic EBV-targeted T-cell therapy in MS.”

Atara is developing another therapy, ATA188, to eliminate EBV-infected B-cells in the central nervous system. ATA188 uses immune cells from donors, not from the patients themselves — an allogenic therapy.

“We are also advancing an ongoing Phase 1 off-the-shelf, allogeneic ATA188 study in patients with progressive MS across clinical sites in the U.S. and Australia. We look forward to continued development of both programs, including our plans to initiate a randomized ATA190 MS study,” said Dietmar Berger, MD, PhD, global head of research and development of Atara Biotherapeutics.

___________________

**Comment**

I can’t help but think this therapy could help many Lyme/MSIDS patients.  EBV is often a player in our illness and many have written about it:

https://madisonarealymesupportgroup.com/2018/04/25/ebv-protein-can-turn-on-genes-for-autoimmune-diseases/

https://madisonarealymesupportgroup.com/2017/11/04/24514/  (EBV – A Key Player in Chronic Illness)

Folks with Lyme/MSIDS have been misdiagnosed with EBV: https://madisonarealymesupportgroup.com/2017/04/11/diagnosed-with-ebv-had-lyme/ and others have it as well as tick-borne infections.

The involvement with numerous viruses is quite common in patients as well.  https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/  For the first time, Garg et al. show a 85% probability for multiple infections including not only tick-borne pathogens but also opportunistic microbes such as EBV and other viruses.

https://madisonarealymesupportgroup.com/2018/04/21/neurological-lyme-disease-what-you-need-to-know/

“Once microbes start becoming active, inflammation increases and immune functions are further compromised, establishing what I call Chronic Immune Dysfunction (CID). In its weakened state, the immune system allows reactivation of viruses such as Epstein Barr virus (EBV), Cytomegalovirus (CMV), and other similar viruses — all of which most people harbor in their tissues. These viruses are commonly associated with neuroinflammation, and they tend to complicate the picture of LNB.”

This study shows elevated B-cells in those with untreated Lyme:  https://www.frontiersin.org/articles/10.3389/fimmu.2018.01634/full

http://simmaronresearch.com/2018/09/post-treatment-lyme-disease-unmasked-immune-holes/  Mouse studies have shown that the Borrelia burgdorferi bacteria that cause Lyme disease hammer the B-cells….

Results

We herein identify plasmablasts as a key B cell population that correlates with resolution of Bb infection and Lyme disease in humans.   The authors

They found that B-cells called plasmablasts were elevated prior to antibiotic treatment in patients who returned to health. Plasmablasts are activated B-cells which circulate for a time in the blood in response to an infection. The higher level of plasmablasts in the recovered patients suggests that these patients simply mounted a stronger immune response to the infection. That was kind of a no-brainer, but the strength of the study was that they were able to specify what part of our amazingly complex immune system the problem was in.

They also determined that the patients who returned to health also exhibited significantly greater clonal expansion: their activated B-cells produced more clones designed to target and get rid of the bacteria. Again, in retrospect, not a surprising finding, but one that does open up a possible treatment option that hasn’t previously been available.

 

 

 

HHS Working Group Calls for Tick-Borne Disease Strategic Plan

https://ohsonline.com/articles/2018/11/15/hhs-working-group-calls-for-strategic-plan.aspx?m=1

HHS Working Group Calls for Tick-Borne Disease Strategic Plan

The Tick-Borne Disease Working Group, a federal advisory committee established by Congress in the 21st Century Cures Act, issued its first report Nov. 14.

The Tick-Borne Disease Working Group, an HHS advisory committee established by Congress in the 21st Century Cures Act, issued its first report Nov. 14. The document recommends that the National Institutes of Health create an NIH tick-borne disease strategic plan to address these diseases, including all stages of Lyme disease; that funding be dedicated within CDC to study babesiosis incidence; that the Department of Defense begin a study of tick-borne disease incidence among active-duty service members and their dependents; and that the Veterans Administration begin a study of tick-borne disease incidence and prevalence among veterans and eligible family members.

The DoD recommendation says the department should compile data on the impact of tick-borne diseases on military readiness and should create education and preparedness programs that address the unique risks service members face during training and on deployment and by their families.

The working group consists of 14 people appointed by the HHS secretary in December 2017. They include scientists, physicians, patients, patient advocates, and representatives of HHS, DoD, and the Office of Management and Budget.

Their report calls Lyme disease a growing public health threat, with about 300,000 new cases reported in the United States every year. A map of U.S. states in the report indicates the hardest-hit states, those reporting more than 12,856 cases each in 2004-2016, include Minnesota, Wisconsin, Pennsylvania, Maryland, Virginia, New York, New Jersey, Massachusetts, and Maine.

Most Lyme disease patients who are diagnosed and treated early can fully recover, but 10-20 percent of patients suffer from persistent symptoms, which for some are chronic and disabling. The report says while studies indicate Lyme disease costs approximately $1.3 billion annually in direct medical costs in the United States,

“a comprehensive understanding of the full economic and societal cost remains unknown. It is likely orders of magnitude higher and potentially a $50- to $100-billion-dollar problem for the United States, although more research is needed.”

On Nov. 14, CDC reported that new data show tick-borne diseases are again on the rise, and that in 2017, state and local health departments reported a record number of cases of tick-borne disease to CDC. Cases of Lyme disease, anaplasmosis/ehrlichiosis, spotted fever rickettsiosis (including Rocky Mountain spotted fever), babesiosis, tularemia, and Powassan virus disease all increased—from 48,610 cases in 2016 to 59,349 cases in 2017. However, the 2017 data capture only a fraction of the number of people with tick-borne illnesses, according to CDC. According to the agency, between 2004 and 2016, the number of reported cases of tick-borne disease doubled and researchers discovered seven new tick-borne pathogens that infect people. The new data are from the Notifiable Disease Surveillance System.

_________________

**Comment**

Bartonella is never mentioned yet it is a HUGE player in this madness.  There is little to no research showing how concurrent infection is playing into this.  Here’s a few recent studies:  https://madisonarealymesupportgroup.com/2018/11/17/investigating-disease-severity-in-an-animal-model-of-concurrent-babesiosis-lyme-disease/  THESE FINDINGS SUGGEST THAT B. BURGDORFERI COINFECTION ATTENUATES PARASITE GROWTH WHILE B. MICROTI PRESENCE EXACERBATES LYME DISEASE-LIKE SYMPTOMS IN MICE.

https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/  For the first time, Garg et al. show a 85% probability for multiple infections including not only tick-borne pathogens but also opportunistic microbes such as EBV and other viruses.
I’m thankful they included Bartonella as that one is often omitted but definitely a player. I’m also thankful for the mention of viruses as they too are in the mix. The mention of the persister form must be recognized as well as many out there deny its existence.

Key Quote:

“Our findings recognize that microbial infections in patients suffering from TBDs do not follow the one microbe, one disease Germ Theory as 65% of the TBD patients produce immune responses to various microbes.”

But there is another important point.

According to this review, 83% of all commercial tests focus only on Lyme (borrelia), despite the fact we are infected with more than one microbe. The review also states it takes 11 different visits to 11 different doctors, utilizing 11 different tests to be properly diagnosed. https://www.news-medical.net/news/20181101/Tick-borne-disease-is-multiple-microbial-in-nature.aspx?

We have many problems, Houston, and much work is being left undone.

 

 

 

Zoonotic Implications of Changing Tick Populations

https://www.americanveterinarian.com/news/zoonotic-implications-of-changing-tick-populations

October 25, 2018

Zoonotic Implications of Changing Tick Populations

As environmental changes allow tick populations to spread, the zoonotic risk of tickborne diseases increases.

By Kate Boatright, VMD

Between 1940 and 2004, the majority of emerging human infectious diseases worldwide were zoonotic. Of these, nearly one-quarter were arthropod vector-borne diseases, with ticks being the most common vector. In the United States, tickborne diseases account for about 95% of vector-borne diseases.

A recent review article in Veterinary Sciences examined many factors of tick biology, including the changing geographic distribution of tick populations and the impact of this change on associated tickborne diseases.

Ixodes Ticks and Associated Pathogens

Ixodid ticks exist worldwide. Warmer temperatures and changing humidity have allowed for northern expansion in North America, Europe, and Russia. Many significant zoonotic pathogens are carried by these ticks:

  • Borrelia burgdorferi, the causative agent of Lyme disease, is now seen throughout the United States, Canada, and Europe.
  • New Borrelia species identified worldwide have been implicated as additional causative agents of Lyme disease (Borrelia mayonii) and a relapsing fever (Borrelia miyamotoi).
  • Babesiosis, caused by over 100 different Babesia species, is especially significant for cattle and humans. Human babesiosis cases are expected to be seen in Canada due to the increased number of Ixodes scapularis ticks, and new Babesia species are now seen in regions not previously known to have babesiosis.
  • Anaplasma phagocytophilum is the causative agent of human granulocytic anaplasmosis (HGA), equine anaplasmosis, and febrile diseases in ruminants, cats, and dogs. Reports of HGA in the United States increased by a factor of 12 between 2001 and 2011.
  • Co-infections are common in individuals exhibiting disease from an Ixodes tick vector. Ten percent of individuals infected with Anaplasma also had antibodies to B burgdorferi or Babesia microti.
Ambylomma Ticks and Ehrlichia

In the United States, Amblyomma americanum ticks have expanded both north and west as white-tailed deer populations have increased in these regions. All life stages of this tick species can feed on humans and deer, increasing the potential for transmission of Ehrlichia chaffeensis and Ehrlichia ewingii, the most common causes of human monocytic ehrlichiosis.

In the rest of the world, other Amblyomma ticks serve as vectors for multiple species of Ehrlichia, including new genetic variants classified as Candidatus Neoehrlichia species in Europe and Asia. For veterinarians, heartwater disease, caused by Ehrlichia ruminantium, is an increasingly important reportable disease of ruminants in Africa and the Caribbean.

Viral Vector-Borne Diseases

Vector-borne viruses are another emerging global zoonotic threat. Many tick species carry viruses of increasing public health importance:

  • Rhipicephalus microplus and Haemaphysalis longicornis ticks in China and Amblyomma americanum in the United States are known vectors of closely related viruses causing severe fever and thrombocytopenia. In the United States, this virus is known as heartland virus.
  • Bourbon virus was recently discovered in the United States.
  • Powassan virus is reemerging in North America.
  • Tickborne encephalitis viruses are broadening in range throughout Europe as reforestation and movement of dogs allows the range of their vector, Dermacentor reticulatus, to expand into Germany, the Netherlands, and Poland.
  • Crimean-Congo hemorrhagic fever virus is spreading to multiple countries in the Mediterranean, likely due to the transportation of its tick vector, Hyalomma marginatum, by birds from Africa, Asia, and Eastern Europe to Central Europe.
Take-Home Message

Practitioners in both veterinary and human medicine must remain aware of the changing geography of ticks and associated vector-borne diseases. The discovery of the Asian tick H longicornis in New Jersey and Virginia should be an important reminder of the fact that

“ticks and tickborne pathogens do not recognize international boundaries.”

Thus, “a robust international disease monitoring network” is needed to protect both human and animal health from both known and emerging tick-borne diseases.
Dr. Boatright, a 2013 graduate of the University of Pennsylvania, is an associate veterinarian in western Pennsylvania. She is actively involved in her state and local veterinary medical associations and is a former national officer of the Veterinary Business Management Association.

________________

**Comment**

Independent Canadian tick researcher states it’s migrating birds and photoperiod allowing tick populations to spread, not climate issues:  https://madisonarealymesupportgroup.com/2018/08/13/study-shows-lyme-not-propelled-by-climate-change/

This groundbreaking study:  https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/ shows a 85% probability for multiple infections in patients suffering from tick borne disease, including not only tick-borne pathogens but also opportunistic microbes such as EBV and other viruses.

Key Quote:

“Our findings recognize that microbial infections in patients suffering from TBDs do not follow the one microbe, one disease Germ Theory as 65% of the TBD patients produce immune responses to various microbes.”

Eighty three percent of all commercial tests focus only on Lyme (borrelia), despite the fact we are infected with more than one microbe. It takes 11 different visits to 11 different doctors, utilizing 11 different tests to be properly diagnosed. https://www.news-medical.net/news/20181101/Tick-borne-disease-is-multiple-microbial-in-nature.aspx?

Time for things to change.

 

 

Prophage-driven Genomic Structural Changes Promote Bartonella Vertical Evolution

https://www.ncbi.nlm.nih.gov/m/pubmed/30346520/

Prophage-driven genomic structural changes promote Bartonella vertical evolution

Genome Biology and Evolution, evy236, https://doi.org/10.1093/gbe/evy236
22 October 2018

Abstract

Bartonella is a genetically diverse group of vector-borne bacteria. Over 40 species have been characterized to date, mainly from mammalian reservoirs and arthropod vectors. Rodent reservoirs harbor one of the largest Bartonella diversity described to date, and novel species and genetic variants are continuously identified from these hosts. Yet, it is still unknown if this significant genetic diversity stems from adaptation to different niches or from intrinsic high mutation rates. Here, we explored the vertical occurrence of spontaneous genomic alterations in 18 lines derived from two rodent-associated Bartonella elizabethae-like strains, evolved in non-selective agar plates under conditions mimicking their vector- and mammalian-associated temperatures, and the transmission cycles between them (i.e. 26 °C, 37 °C, and alterations between the two), using mutation accumulation experiments.

After ∼1000 generations, evolved genomes revealed few point mutations (average of one-point mutation per line), evidencing conserved single-nucleotide mutation rates. Interestingly, three large structural genomic changes (two large deletions and an inversion) were identified over all lines, associated with prophages and surface adhesin genes. Particularly, a prophage, deleted during constant propagation at 37 °C, was associated with an increased autonomous replication at 26 °C (the flea-associated temperature). Complementary molecular analyses of wild strains, isolated from desert rodents and their fleas, further supported the occurrence of structural genomic variations and prophage-associated deletions in nature. Our findings suggest that structural genomic changes represent an effective intrinsic mechanism to generate diversity in slow-growing bacteria and emphasize the role of prophages as promoters of diversity in nature.

___________________

**Comment**

Bacteriophages or simply phages were discovered in the early 1900’s and are viruses which infect a bacterium causing horizontal gene transfer which in turn causes bacterial evolution.  

If you don’t know it yet, what goes into a Lyme/MSIDS patient is not what comes out.  These critters morph inside us turning into something quite different, which is one reason this complex is so difficult to treat.

When I read a book on antibiotic resistance, thankfully something that is not occurring yet in Lyme/MSIDS with few exceptions, I learned of phage therapy.  If this interests you check this out (located in the Republic of Georgia):  https://www.phagetherapycenter.com/pii/PatientServlet?command=static_phagetherapy

News articles on phage therapy:  https://www.phagetherapycenter.com/pii/PatientServlet?command=static_news&secnavpos=4&language=0

I’ve been told phage therapy wouldn’t work with Lyme/MSIDS due to the lack of host specificity.  In other words, the phage must directly line up with the specific bacteria in order to work.  Also, most of us are dealing with more than one bacteria, and battle worms, parasites, and other lovely beasts thrown into the mix to keep us humble.

The take home from this abstract is that the bacteria we are infected with are intelligent and stealthy, changing within us to further their goals.  They don’t want to kill us, just maim and weaken us so they can live long, full lives.  Also, notice “slow-growing bacteria,” which should serve as a clue to practitioners that these types of organisms scoff at 21 days of antibiotics.

Diagnosing & Treating Autoimmune Encephalitis in Patients with Persistent Lyme Symptoms

 Approx. 47 Min.

Dr. Frid: Diagnosing and Treating Infectious Induced AE in Patients with Persistent Lyme Symptoms

Dr. Elena Frid talk Diagnosing and Treating Infections Induced Autoimmune Encephalitis in Patient’s with Persistent Lyme Symptoms to physicians and patients at the Central Mass Lyme conference

_________________

More with Dr. Frid:  https://madisonarealymesupportgroup.com/2018/03/14/dr-frid-children-lyme/

https://madisonarealymesupportgroup.com/2017/11/24/dr-frid-lyme-parkinsons-autoimmunity/

https://madisonarealymesupportgroup.com/2017/08/09/meet-the-lyme-disease-experts-dr-elena-frid-and-more/

https://madisonarealymesupportgroup.com/2018/04/17/dr-frid-mary-beth-pfeiffer-on-fox5/

More on Lyme encephalitis:  https://madisonarealymesupportgroup.com/2018/07/03/lyme-meningoencephalitis-masquerading-as-normal-pressure-hydrocephalus/

https://madisonarealymesupportgroup.com/2017/10/30/tick-borne-encephalitis-found-in-serbian-dogs-horses-wild-boar-and-roe-deer/

https://madisonarealymesupportgroup.com/2017/10/01/panspandas-steroids-autoimmune-disease-lymemsids-the-need-for-medical-collaboration/  There is often involvement with Lyme/MSIDS in both Autism and PANS.  Here we see a story of Patrik, who was diagnosed with Lyme Disease which then morphs into Autoimmune encephalopathy. It took 10 years and 20 doctors to obtain the Lyme disease diagnosis behind his autoimmune condition.

How many people are slipping through this crack?

This pivotal study shows the complex issue of coinfections and the Lyme persister organism in lowering patients’ immune system thereby opening the door to opportunistic infections which can cause encephalopathy:  https://madisonarealymesupportgroup.com/2018/10/30/study-shows-lyme-msids-patients-infected-with-many-pathogens-and-explains-why-we-are-so-sick/